Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ambre Bott"'
Autor:
Ambre Bott, Bart Neyns, Sofie Wilgenhof, Teofila Seremet, Max Schreuer, Ines Chevolet, Yanina Jansen, Geert Maertens, Sari Van Den Herrewegen, Geert Meersseman
Publikováno v:
Melanoma Research. 26:157-163
Small fragments of cell-free DNA that are shed by normal and tumor cells can be detected in the plasma of patients with advanced melanoma. Quantitative measurement of BRAF V600 mutant DNA within the cell-free DNA holds promise as a tumor-specific bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7a21f17d02c83d543852e1ee15deac
https://doi.org/10.1097/cmr.0000000000000224
https://doi.org/10.1097/cmr.0000000000000224
Autor:
Teofila Seremet, Ines Chevolet, Yanina Jansen, Ronald Buyl, Bart Jacobs, Bart Neyns, Geert Maertens, Ambre Bott, Max Schreuer, Geert Meersseman, Sofie Wilgenhof, Sari Van Den Herrewegen
Publikováno v:
Journal of Translational Medicine
BACKGROUND: BRAF V600 mutant circulating cell-free tumor DNA (BRAF V600mut ctDNA) could serve as a specific biomarker in patients with BRAF V600 mutant melanoma. We analyzed the value of BRAF V600mut ctDNA from plasma as a monitoring tool for advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e828897bb7fe5a9d0c90019cbc289283
https://pubmed.ncbi.nlm.nih.gov/27095081
https://pubmed.ncbi.nlm.nih.gov/27095081
Autor:
Ambre Bott, Bart Neyns, Sofie Wilgenhof, Teofila Seremet, Yanina Jansen, Max Schreuer, Geert Maertens, Ines Chevolet, Geert Meersseman
Publikováno v:
Journal of Clinical Oncology. 33:9015-9015
9015 Background: Analysis of BRAF V600 mutant cell-free tumor DNA (ctDNA) from plasma is under consideration as a biomarker in pts with advanced melanoma. Methods: Plasma samples were obtained from...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9899313470cae1df257491f7db8d401c
https://doi.org/10.1200/jco.2015.33.15_suppl.9015
https://doi.org/10.1200/jco.2015.33.15_suppl.9015